Testing bevacizumab for breathing problems from ARDS
Part of Lungs & breathing clinical trials.
This trial tests if bevacizumab can help people with ARDS (a serious lung condition) breathe better. It is for patients with mild, moderate, or severe ARDS who are already in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have ARDS (a lung injury causing breathing trouble) that is mild, moderate, or severe.
- You cannot be allergic to bevacizumab or similar medicines.
- You cannot have serious liver disease (cirrhosis with a Child-Pugh score of 7 or higher).
- You cannot be on dialysis before coming to the hospital, and your urine test for protein must be low.
- You must not have a history of serious bleeding, uncontrolled high blood pressure, blood clots, or other major heart or blood vessel problems in the past few months.
- You cannot be taking certain blood thinners (like high-dose aspirin or clopidogrel) unless they are closely monitored.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial tests a drug called vilobelimab for people with moderate or severe ARDS (a serious lung condition). It aims to find if this treatment can help improve breathing and outcomes.
This trial tests a new way of setting the breathing machine for people with a lung condition called ARDS. It may help improve breathing and recovery compared to standard care.
This trial tests a new treatment called IC14 for people in the hospital on a breathing machine for ARDS (a severe lung injury). The study aims to see if IC14, which blocks a protein involved in inflammation, can help the lungs heal faster.
This study compares a more careful ventilation approach for people with severe lung breathing failure (ARDS). It aims to improve outcomes by using a specific strategy for how the ventilator controls breathing.
This trial tests a new treatment using stem cells from umbilical cords, given through an IV, for people with severe ARDS. The goal is to see if it's safe and helps improve breathing.
Hear when a new ARDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.